Hibiki Path Advisors Website cdp.net

Equity investing and advisory business

11/Mar/2022 – IR Enhancement Proposal to MatsukiyoCocokara & Co.

You can read this content about 2 minute(s)

Hibiki Path Advisors(”Hibiki”)made a presentation (link below) on March 11th, to managements of MatsukiyoCocokara & Co.(”MatsukiyoCocokara”).

Hibiki keeps being a shareholder of MatsukiyoCocokara with a strong confidence and expectation that the company leads the industry becoming the No.1 after the merger.  On the other hand, we believe shares of the company are traded under significantly lower valuation. This presentation was made so that MatsukiyoCocokara can attract market participants by appealing synergy by integration and its uniquely differentiated strength.

This document does not constitute an offer, recommendation or solicitation to buy or sell any security or enter into any other transaction. Hibiki does not purport to provide any investment, financial, legal or other expert advice or recommendation in this document.

“AGGRESSIVE” IR AS NO.1 DRUGSTORE IN JAPAN